Annals of Hematology

, Volume 93, Issue 2, pp 309–315 | Cite as

Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding

  • David Grimaldi
  • Florence Canouï-Poitrine
  • Laure Croisille
  • Ketty Lee
  • Françoise Roudot-Thoraval
  • Laetitia Languille
  • Medhi Khellaf
  • Marc Michel
  • Bertrand Godeau
  • Philippe BierlingEmail author
Original Article


Immune thrombocytopenia (ITP) results in part from the presence of platelet antibodies, which can be demonstrated by the Monoclonal Antibody-Specific Immobilization of Platelet Antigens (MAIPA) assay. The aim of our study was to correlate the presence of antiplatelet autoantibodies and the natural history of ITP. We performed a retrospective, single-center study of 108 adults with newly diagnosed ITP who had indirect MAIPA assay performed at disease onset. Chronic ITP was defined by the presence of thrombocytopenia after 1 year. Bleeding diathesis was evaluated with a bleeding score. At baseline, patients with a positive indirect MAIPA have a greater bleeding score than patients with negative MAIPA assay [median (interquartile) = 8 (6–12) vs 2 (0–6), p = 0.002]. Patients with a positive indirect MAIPA also had a higher rate of chronic ITP (92.9 vs 68.7 %, p = 0.06). In multivariate analysis, a positive indirect MAIPA result and a platelet count at onset ≥10 × 109/L remained independently associated with chronic ITP [adjusted OR (aOR) = 8.01; 95 % confidence interval (CI), 0.98–66.6; p = 0.05 and aOR = 3.09; 95 % CI, 1.18–8.10; p = 0.02, respectively]. Furthermore, when we analyzed together the results of direct (n = 41) and indirect MAIPA, the same results were observed. Thus, indirect MAIPA positivity at disease onset is associated with more severe hemorrhage and predicts a chronic course in adult ITP patients. MAIPA assay could be useful in the management of ITP patients when it is performed at diagnosis.


Immune thrombocytopenia MAIPA assay Chronic ITP Platelet autoantibodies 



The authors would like to gratefully thank Aurélie Le Thuaut for her technical help in statistical analysis. DG, BG and PB designed the study. BG, PB, MK, MM enrolled the patients. DG and LL recorded the data of the study. FCP and FRT performed the statistical analysis. KL, LC and PB performed MAIPA test. DG, FCP, MK, MM, BG and PB wrote the manuscript.

Supplementary material

277_2013_1855_MOESM1_ESM.docx (17 kb)
ESM 1 (DOCX 16 kb)


  1. 1.
    Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386–2393PubMedCrossRefGoogle Scholar
  2. 2.
    Cines DB, Bussel JB, Liebman HA, Luning Prak ET (2009) The ITP syndrome: pathogenic and clinical diversity. Blood 113:6511–6521PubMedCrossRefGoogle Scholar
  3. 3.
    Cooper N, Bussel J (2006) The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol 133:364–374PubMedCrossRefGoogle Scholar
  4. 4.
    Cines DB, Blanchette VS (2002) Immune thrombocytopenic purpura. N Engl J Med 346:995–1008PubMedCrossRefGoogle Scholar
  5. 5.
    Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115:168–186PubMedCrossRefGoogle Scholar
  6. 6.
    Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C (1987) Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 70:1722–1726PubMedGoogle Scholar
  7. 7.
    McMillan R (2003) Antiplatelet antibodies in chronic adult immune thrombocytopenic purpura: assays and epitopes. J Pediatr Hematol Oncol 25(Suppl 1):S57–S61PubMedCrossRefGoogle Scholar
  8. 8.
    Brighton TA, Evans S, Castaldi PA, Chesterman CN, Chong BH (1996) Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 88:194–201PubMedGoogle Scholar
  9. 9.
    Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117:4190–4207PubMedCrossRefGoogle Scholar
  10. 10.
    (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120: 574–596Google Scholar
  11. 11.
    Arnold DM, Santoso S, Greinacher A, (2012) Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia. J Thromb HaemostGoogle Scholar
  12. 12.
    George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3–40PubMedGoogle Scholar
  13. 13.
    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRefGoogle Scholar
  14. 14.
    Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DEG PG, Koike T, Meroni PL, Reber G, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306PubMedCrossRefGoogle Scholar
  15. 15.
    Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B (2005) Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematologica 90:829–832PubMedGoogle Scholar
  16. 16.
    Purpura thrombopénique immunologique de l'enfant et de l'adulte. Protocole national de diagnostic et de soins. Haute Autorité de Santé.
  17. 17.
    Godeau B, Piette JC, Fromont P, Intrator L, Schaeffer A, Bierling P (1997) Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome. Br J Haematol 98:873–879PubMedCrossRefGoogle Scholar
  18. 18.
    Tchernia G, Morel-Kopp MC, Yvart J, Kaplan C (1993) Neonatal thrombocytopenia and hidden maternal autoimmunity. Br J Haematol 84:457–463PubMedCrossRefGoogle Scholar
  19. 19.
    Taub JW, Warrier I, Holtkamp C, Beardsley DS, Lusher JM (1995) Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura. Am J Hematol 48:104–107PubMedCrossRefGoogle Scholar
  20. 20.
    Sikorska A, Konopka L, Maslanka K (2008) The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura. Int J Lab Hematol 30:58–64PubMedCrossRefGoogle Scholar
  21. 21.
    Berchtold P, Wenger M (1993) Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment. Blood 81:1246–1250PubMedGoogle Scholar
  22. 22.
    Warner MN, Moore JC, Warkentin TE, Santos AV, Kelton JG (1999) A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol 104:442–447PubMedCrossRefGoogle Scholar
  23. 23.
    Berchtold P, Muller D, Beardsley D, Fujisawa K, Kaplan C, Kekomaki R, Lipp E, Morell-Kopp MC, Kiefel V, McMillan R, von dem Borne AE, Imbach P (1997) International study to compare antigen-specific methods used for the measurement of antiplatelet autoantibodies. Br J Haematol 96:477–483PubMedCrossRefGoogle Scholar
  24. 24.
    McMillan R, Wang L, Tani P (2003) Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Haemost 1:485–491PubMedCrossRefGoogle Scholar
  25. 25.
    Nomura S, Yanabu M, Soga T, Kido H, Fukuroi T, Yamaguchi K, Nagata H, Kokawa T, Yasunaga K (1991) Analysis of idiopathic thrombocytopenic purpura patients with antiglycoprotein IIb/IIIa or Ib autoantibodies. Acta Haematol 86:25–30PubMedCrossRefGoogle Scholar
  26. 26.
    Fabris F, Scandellari R, Ruzzon E, Randi ML, Luzzatto G, Girolami A (2004) Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura. Blood 103:4562–4564PubMedCrossRefGoogle Scholar
  27. 27.
    Webster ML, Sayeh E, Crow M, Chen P, Nieswandt B, Freedman J, Ni H (2006) Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies. Blood 108:943–946PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • David Grimaldi
    • 1
  • Florence Canouï-Poitrine
    • 2
    • 3
  • Laure Croisille
    • 1
    • 4
  • Ketty Lee
    • 1
    • 4
  • Françoise Roudot-Thoraval
    • 2
    • 3
  • Laetitia Languille
    • 1
  • Medhi Khellaf
    • 1
  • Marc Michel
    • 1
  • Bertrand Godeau
    • 1
  • Philippe Bierling
    • 1
    • 4
    Email author
  1. 1.Service de Médecine interne, Centre de référence des cytopénies auto-immunes, hôpital Henri Mondor, AP-HPUniversité Paris EstCréteilFrance
  2. 2.Université Paris EstCréteilFrance
  3. 3.AP-HP, Service de santé publiqueHôpital Henri MondorCréteilFrance
  4. 4.Etablissement Francais du SangHopital Henri MondorCreteilFrance

Personalised recommendations